Invetech presents on Cell Therapy commercialization strategies at the 17th Annual ISCT Meeting

05 May 2011

David James

David James, Invetech's Director of Life Science and Pharmaceutical, will present at the 17th Annual ISCT meeting, to be held later this month in Rotterdam, The Netherlands. The ISCT is a premier global association started to help drive the translation of scientific research to deliver innovative cellular therapies to patients.

David, in conjunction with key industry leaders, will address key issues influencing strategies for cell therapy commercialization. Speaking over two days, David will discuss approaches for advanced automation for Autologous processing, including the technologies available today, and why, when and how to start planning for, and implementing automation during clinical development.

Strategies for Commercialization
Track 3: Advanced Automation for Autologous Processing
Thursday 19 May 2011
Time: 3:30pm - 5:00pm

Strategies for Commercialization
Track 5: Decreasing Corporate Risk for Cell Therapy Programs
Friday 20 May 2011
Time: 10:45am - 12:15pm

17th Annual ISCT Meeting
May 18-21, 2011
De Doelen Congress Centre
Postbus 972
3000 AZ Rotterdam
The Netherlands

Further Press Information

Alan Morris, Phone: +613 9211 7815, Fax: +613 9211 7703. Media Inquiries.